Comment
doi: 10.1067/mem.2003.111.
FDA "black box" labeling
Affiliations
- PMID: 12658256
- DOI: 10.1067/mem.2003.111
Item in Clipboard
Comment
FDA "black box" labeling
Ann Emerg Med.
2003 Apr.
No abstract available
Comment in
-
Droperidol and the black box warning.Ann Emerg Med. 2004 Jan;43(1):139-40. doi: 10.1016/j.annemergmed.2003.05.006. Ann Emerg Med. 2004. PMID: 15259182 No abstract available.
Comment on
-
Droperidol, QT prolongation, and sudden death: what is the evidence?Ann Emerg Med. 2003 Apr;41(4):546-58. doi: 10.1067/mem.2003.110. Ann Emerg Med. 2003. PMID: 12658255 Review.
Similar articles
-
Droperidol, QT prolongation, and sudden death: what is the evidence?Ann Emerg Med. 2003 Apr;41(4):546-58. doi: 10.1067/mem.2003.110. Ann Emerg Med. 2003. PMID: 12658255 Review.
-
FDA response to droperidol black box warning editorials.Anesth Analg. 2008 May;106(5):1585. doi: 10.1213/ane.0b013e3181693844. Anesth Analg. 2008. PMID: 18420886 No abstract available.
-
Pro: The Food and Drug Administration Black box warning on droperidol is not justified.Anesth Analg. 2008 May;106(5):1414-7. doi: 10.1213/ane.0b013e31816ba463. Anesth Analg. 2008. PMID: 18420854 No abstract available.
-
Con: The black box warning on droperidol should not be removed (but should be clarified!).Anesth Analg. 2008 May;106(5):1418-20. doi: 10.1213/ane.0b013e3181684e6a. Anesth Analg. 2008. PMID: 18420855 No abstract available.
-
Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system.Curr Opin Anaesthesiol. 2010 Jun;23(3):423-7. doi: 10.1097/aco.0b013e328338c9f7. Curr Opin Anaesthesiol. 2010. PMID: 20446348 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
